甲哌卡因与布比卡因脊麻用于全髋关节置换术后早期下地活动的比较
这项随机对照试验纳入154例初次全髋关节置换患者,比较52.5 mg甲哌卡因、11.25 mg重比重布比卡因和12.5 mg等比重布比卡因脊麻的效果。甲哌卡因组在术后3至3.5小时下地活动的比例更高(70.0% vs 37.7% vs 17.6%,P<0.001),同日出院率更高(46.0% vs 24.5% vs 21.5%,P=0.014),住院时间最短。
要点
- 甲哌卡因脊麻可让全髋关节置换患者更早下地活动并提高同日出院率。
- 甲哌卡因组术后早期疼痛和阿片消耗仅短暂高于布比卡因组。
- 三组短暂神经症状、尿潴留、低血压等不良反应无差异。
核心结论
- 甲哌卡因脊麻患者比重比重和等比重布比卡因患者更早下地活动,且更可能同日出院。
- 若选择脊麻,甲哌卡因可能有利于门诊全髋关节置换候选患者。
研究设计与样本
- 随机对照试验,纳入ASA I至III级初次全髋关节置换患者,按1:1:1随机分为52.5 mg甲哌卡因组、11.25 mg重比重布比卡因组和12.5 mg等比重布比卡因组。
- 共154例患者,甲哌卡因组50例,重比重布比卡因组53例,等比重布比卡因组51例。
主要发现
- 术后3至3.5小时下地活动比例:甲哌卡因组35/50(70.0%),重比重布比卡因组20/53(37.7%),等比重布比卡因组9/51(17.6%),P<0.001。
- 甲哌卡因组运动功能恢复更早。
- 甲哌卡因组术后早期疼痛和阿片消耗更高,但仅限早期。
- 同日出院比例:甲哌卡因组23/50(46.0%),重比重布比卡因组13/53(24.5%),等比重布比卡因组11/51(21.5%),P=0.014。
- 甲哌卡因组住院时间最短;短暂神经症状、尿潴留、低血压、肌紧张或头晕无差异。
临床怎么用
- 对于拟行初次全髋关节置换且选择脊麻的患者,可考虑使用甲哌卡因以促进早期下地活动和同日出院。
- 需注意甲哌卡因组术后早期疼痛和阿片消耗可能更高,应做好早期镇痛准备。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early ambulation after total hip arthroplasty predicts early discharge. Spinal anesthesia is preferred by many practices but can delay ambulation, especially with bupivacaine. Mepivacaine, an intermediate-acting local anesthetic, could enable earlier ambulation than bupivacaine. This study was designed to test the hypothesis that patients who received mepivacaine would ambulate earlier than those who received hyperbaric or isobaric bupivacaine for primary total hip arthroplasty. METHODS: This randomized controlled trial included American Society of Anesthesiologists Physical Status I to III patients undergoing primary total hip arthroplasty. The patients were randomized 1:1:1 to 52.5 mg of mepivacaine, 11.25 mg of hyperbaric bupivacaine, or 12.5 mg of isobaric bupivacaine for spinal anesthesia. The primary outcome was ambulation between 3 and 3.5 h. Secondary outcomes included return of motor and sensory function, postoperative pain, opioid consumption, transient neurologic symptoms, urinary retention, intraoperative hypotension, intraoperative muscle tension, same-day discharge, length of stay, and 30-day readmissions. RESULTS: Of 154 patients, 50 received mepivacaine, 53 received hyperbaric bupivacaine, and 51 received isobaric bupivacaine. Patient characteristics were similar among groups. For ambulation at 3 to 3.5 h, 35 of 50 (70.0%) of patients met this endpoint in the mepivacaine group, followed by 20 of 53 (37.7%) in the hyperbaric bupivacaine group, and 9 of 51 (17.6%) in the isobaric bupivacaine group (P < 0.001). Return of motor function occurred earlier with mepivacaine. Pain and opioid consumption were higher for mepivacaine patients in the early postoperative period only. For ambulatory status, 23 of 50 (46.0%) of mepivacaine, 13 of 53 (24.5%) of hyperbaric bupivacaine, and 11 of 51 (21.5%) of isobaric bupivacaine patients had same-day discharge (P = 0.014). Length of stay was shortest in mepivacaine patients. There were no differences in transient neurologic symptoms, urinary retention, hypotension, muscle tension, or dizziness. CONCLUSIONS: Mepivacaine patients ambulated earlier and were more likely to be discharged the same day than both hyperbaric bupivacaine and isobaric bupivacaine patients. Mepivacaine could be beneficial for outpatient total hip arthroplasty candidates if spinal is the preferred anesthesia type.
引用
- Schwenk ES, Kasper VP, Smoker JD, et al. Mepivacaine versus Bupivacaine Spinal Anesthesia for Early Postoperative Ambulation. Anesthesiology. 2020. PMID: 32852904. doi:10.1097/ALN.0000000000003480
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。